// App-Quantinova.ai

TMP101 2016 ASA : Safety and Outcome of High Doses IV Milirinone in Subarachnoid Hemorrhage With Refractory Vasospasm

Researchers

Presenter

  • Abdulrahman Alturki

Principal Investigators

  • Mohammad Badawy

  • Justin Letourneau

  • Marcelo Lannes

  • Mark Angle

  • Benjamin Lo

  • Jeanne Teitelbaum

Medical Centers

  • Montreal Neurological Hospital, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Subarachnoid hemorrhage

  • Vasospasm

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Milrinone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved